CFLT · As filed with the SEC

Confluent balance sheet, by quarter

The statement as Confluent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousandsQ4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
ASSETS
Current assets:
Cash and cash equivalents347,210298,537295,591278,561385,980322,606311,328336,373
Marketable securities1,706,7621,691,2411,645,0321,638,0161,524,5831,536,8871,619,8531,570,586
Accounts receivable, net390,752356,397357,607297,862314,306278,667257,485199,842
Deferred contract acquisition costs54,54549,81447,65846,14947,27144,81244,43343,214
Prepaid expenses and other current assets107,744102,86995,60682,25079,17983,22174,13576,102
Total current assets2,607,0132,498,8582,441,4942,342,8382,351,3192,266,1932,307,2342,226,117
Property and equipment, net93,17989,26086,96281,69778,68073,15866,79161,627
Operating lease right-of-use assets4,9365,7916,9327,9238,8189,9899,9979,176
Goodwill and intangible assets, net——————54,487,00054,988,000
Goodwill164,406164,406164,406164,406164,406164,366——
Intangible assets, net6,0546,5256,9977,4637,9248,704——
Deferred contract acquisition costs, non-current77,73770,54868,47369,06971,46872,16774,25173,508
Other assets, non-current31,94541,71742,14425,27812,29613,43215,70614,213
Total assets2,985,2702,877,1052,817,4082,698,6742,694,9112,608,0092,528,4662,439,629
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable20,70811,76511,4915,9837,53115,51613,9901,882
Accrued expenses and other liabilities182,735154,441167,839141,922194,250158,914166,77796,739
Operating lease liabilities8,1789,3939,2519,0938,69410,73810,57410,061
Deferred revenue468,984447,012424,293372,870378,771349,787328,845330,516
Total current liabilities680,605622,611612,874529,868589,246534,955520,186439,198
Operating lease liabilities, non-current1,2052,0644,4546,7359,13811,41312,56613,284
Deferred revenue, non-current29,65528,25131,35632,51130,43024,58819,60817,145
Convertible senior notes, net1,095,9881,095,0191,094,0511,093,0941,092,1491,091,1831,090,2191,089,266
Other liabilities, non-current8,67810,21011,00611,13312,72211,55212,02335,519
Total liabilities1,816,1311,758,1551,753,7411,673,3411,733,6851,673,6911,654,6021,594,412
Stockholders’ equity:
Preferred stock, par value of $0.00001 per share; 10,000 shares authorized as of December 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of December 31, 2025 and December 31, 202400000000
Class A Common Stock33222222
Class B Common Stock11111111
Additional paid-in capital3,447,9703,317,9563,192,3493,079,2602,953,0802,826,0532,702,9802,584,665
Accumulated other comprehensive income (loss)5,6566,23410,0552,860(2,641)9,424(2,101)(2,333)
Accumulated deficit(2,284,491)(2,205,244)(2,138,740)(2,056,790)(1,989,216)(1,901,162)(1,827,018)(1,737,118)
Total stockholders’ equity1,169,1391,118,9501,063,6671,025,333961,226934,318873,864845,217
Total liabilities and stockholders’ equity2,985,2702,877,1052,817,4082,698,6742,694,9112,608,0092,528,4662,439,629

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.